Paragon Associates & Paragon Associates II Joint Venture’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,000
Closed -$748K 15
2022
Q4
$748K Buy
+10,000
New +$712K 1.39% 15

Other funds holding HOLX

Paragon Associates & Paragon Associates II Joint Venture's HOLX Position: Q1 2023 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Hologic (HOLX) in Q1 2023, closing a stake of 10,000 shares — an estimated $748K sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in HOLX in Q4 2022 and held it in 1 quarter. The position peaked at $748K in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Paragon Associates & Paragon Associates II Joint Venture reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Paragon Associates & Paragon Associates II Joint Venture sold 10,000 Hologic shares in Q1 2023, an estimated $748K.
  • Paragon Associates & Paragon Associates II Joint Venture first reported a position in Hologic in Q4 2022 and held it in 1 quarter.
  • Paragon Associates & Paragon Associates II Joint Venture's Hologic position peaked at $748K in Q4 2022.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2023, filed 15 May 2023.